Asia is home to more than half of the world's population with fast growing healthcare markets. Coupled with major demographic shifts over the coming decades, this will open up vast opportunities for biomedical and healthcare providers. Asia's ageing population and the rising prevalence of developed world diseases associated with changing lifestyles hold immense opportunities for the drug and medication market. This is further fuelled by rising government healthcare budgets and the introduction of health insurance schemes across the region. Increasing disposable incomes and consumer healthcare awareness are also expected to fuel demand for non-essential and therapeutic treatments. Singapore's vision is to be the Biopolis of Asia, a leading international biomedical sciences cluster for the region. It aims to be the hub where companies can impact global health by spearheading R&D, manufacturing and headquarter activities.
An interconnected R&D sector and healthcare industry
Singapore is Asia's fastest-growing bio-cluster, spending more than US$1.1 billion on biomedical R&D annually. It is home to an invaluable network of research institutes, corporate labs and public hospitals to foster world-leading innovation. Multi-national corporations (MNCs) are capitalising on Singapore's excellent R&D infrastructure and scientific expertise. Novartis, Merck, Roche, GSK, Johnson & Johnson and Abbott have regional headquarters in the country, along with the top 10 global medical technology companies. This makes Singapore a thriving pool of cutting-edge expertise on healthcare and biomedical sciences in this region.
Gateway to Asia
Working from Singapore's strategic base, the largest names in the biomedical sciences are developing innovative medical solutions for the fast-growing healthcare markets in the region. The international medical industry is also leveraging Singapore’s numerous healthcare events, biomedical conferences and medical exhibitions to meet Asia. Big-time events such as BioPharma Asia Convention and MEDLAB Asia Pacific gather the world's leading pharmaceutical, biotechnology companies and healthcare professionals in Singapore to exchange insights and explore biomedical advancements.
The finest healthcare system in Asia
The city-state has a world-renowned healthcare industry, earning Singapore a reputation as the go-to place for complex medical procedures.
Our Focus Moving Ahead
Innovative discoveries and technologies
Singapore has extensive R&D networks and investments, and a reputation as a centre of excellence for knowledge and innovation in healthcare. This supports business events showcasing innovative healthcare and biomedical technologies, and the development of intelligent solutions for the healthcare sector.
Holistic healthcare design and treatment
As healthcare adopts more holistic care delivery models, different parts of the healthcare value chain needs to come together to develop such methods. Singapore’s interconnected biocluster enables business events that gather movers and shakers from a wide variety of fields within the medical community to cross-pollinate ideas and generate cross-industry solutions
Ageing and rehabilitative healthcare
The ageing population places a greater demand on the healthcare industry. Events like Medical Fair Asia and RehabTech Asia have been successful, indicating a growing demand for intelligent technologies and strategies in gerontology.